Estrogen and Xenoestrogens in Breast Cancer

Toxicologic Pathology - Tập 38 Số 1 - Trang 110-122 - 2010
Sandra V. Fernandez1, J. Russo2
1Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
2Breast Cancer Research Laboratory, Fox Chase Cancer#R#Center, Philadelphia, PA, USA, [email protected]

Tóm tắt

There is growing concern that estrogenic environmental compounds that act as endocrine-disrupting chemicals might potentially have adverse effects on hormone-sensitive organs such as the breast. This concern is further fueled by evidence indicating that natural estrogens, specifically 17β-estradiol, are important factors in the initiation and progression of breast cancer. We have developed an in vitro—in vivo model in which we have demonstrated the carcinogenicity of E2 in human breast epithelial cells MCF-10F. Hypermethylation of NRG1, STXBP6, BMP6, CSS3, SPRY1, and SNIP were found at different progression stages in this model. The use of this powerful and unique model has provided a tool for exploring whether bisphenol A and butyl benzyl phthalate have relevance in the initiation of breast cancer. These studies provide firsthand evidence that the natural estrogen 17β-estradiol and xenoestrogenic substances like bisphenol A are able to induce neoplastic transformation in human breast epithelial cells.

Từ khóa


Tài liệu tham khảo

10.1210/en.2003-1174

1999, Environ Health Perspect, 107, 89, 10.1289/ehp.9910789

10.1002/ijc.20389

10.1073/pnas.93.9.4045

10.1016/S0140-6736(03)14065-2

10.1093/oxfordjournals.epirev.a036116

10.1080/0265203031000119061

10.1289/ehp.95103608

2003, News, 17

10.1289/ehp.7534

10.1001/jama.289.24.3243

2006, Breast Cancer Res, 8, 5

2008, Breast Cancer Res, 10, 11

10.1002/(SICI)1097-0215(19990118)80:2<250::AID-IJC14>3.0.CO;2-D

10.1093/jnci/90.11.814

2005, Clin Cancer Res, 11, 909s, 10.1158/1078-0432.909s.11.2

10.1016/S0140-6736(97)08233-0

10.1016/S0890-6238(01)00200-3

10.1016/S0890-6238(03)00037-6

2005, Int J Oncol, 26, 691

10.1002/ijc.21590

2006, Proc Am Assoc Cancer Res, 47, 1590

2005, Altern Med Rev, 10, 36

10.1093/toxsci/58.2.350

10.1046/j.1525-1373.2000.22402.x

10.1289/ehp.97105802

10.1056/NEJM199207303270505

10.1126/science.1957166

10.1083/jcb.140.1.159

10.1262/jrd.16075

10.1289/ehp.5993

10.1158/0008-5472.CAN-07-1371

10.1001/jama.1997.03550170037029

10.1093/humrep/17.11.2839

1999, Concise International Chemical Assessment Document 17, Butyl benzyl phthalate

10.1289/ehp.95103582

10.1093/jnci/94.8.606

10.1210/endo.132.6.8504731

2005, Int J Oncol, 26, 423

10.1073/pnas.93.19.10366

10.1016/S0013-9351(03)00086-0

10.1001/jama.289.24.3254

10.1158/0008-5472.CAN-04-1207

10.1242/dev.00715

10.1507/endocrj.46.513

10.1289/ehp.5512

10.1021/tx0001833

10.1038/sj.leu.2400932

10.1289/ehp.96104298

10.1016/S1570-0232(02)00547-0

10.1038/303767a0

10.1095/biolreprod65.4.1271

10.1001/jama.288.3.321

10.1074/jbc.M006777200

10.1096/fj.05-5399com

10.1016/S0960-0760(03)00390-X

10.1016/S0960-0760(01)00183-2

10.1128/MCB.21.13.4265-4275.2001

10.1289/ehp.021100703

10.1093/glycob/12.4.57R

10.1038/sj.onc.1205608

10.1016/S0960-0760(98)00027-2

1990, Cancer Res, 50, 6075

10.1016/S0890-6238(02)00005-9

10.1016/S0024-3205(99)00502-0

10.1073/pnas.1436402100

10.1007/s00244-002-2124-0

10.1083/jcb.131.1.215

1998, Toxicol Sci, 46, 282